Skip to main content
Psychopharmacology Bulletin All Volumes & Issues VOL 49 No. 1 An Approach to...
COMPLICATED CASE HISTORIES

An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome

Psychopharmacology Bulletin 49(1) :84-91 , 2019/02/15

Abstract

Neuroleptic malignant syndrome is a rare, idiosyncratic emergency associated with exposure to dopamine antagonists, commonly antipsychotic drugs. The typical clinical picture consists of altered consciousness, muscular rigidity, fever, and autonomic instability. While the condition has generally been well described, the pathophysiology is still poorly understood. The importance of this case report is to highlight the lack of robust evidence-based treatment for this emergency. We submit an approach to the pharmacotherapy of neuroleptic malignant syndrome based on the available evidence.

Access This Article

Choose an access option below to view the full article.

Subscriber Access

If you or your institution has a subscription, log in to access this article.

Log In

Purchase Article

Buy single-article access with a one-time purchase.

$30.00
Add to Cart

How to Cite

Roland van Rensburg, Eric H. Decloedt. An Approach to the Pharmacotherapy of Neuroleptic Malignant Syndrome. Psychopharmacology Bulletin. 2019/02/15; 49(1):84-91.